Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ANTARES PHARMA, INC.

(ATRS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société ANTARES PHARMA, INC.
09/08ANTARES PHARMA : to Participate in the H.C. Wainright 23rd Annual Global Investment Confer..
PU
09/08Antares Pharma to Participate in the H.C. Wainwright 23rd Annual Global Investment Conf..
GL
08/18ANTARES PHARMA, INC. : Regulation FD Disclosure (form 8-K)
AQ
08/06Antares pharma reports second quarter 2021 financial and operating resultsewing
AQ
08/05ANTARES PHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS O..
AQ
08/05ANTARES PHARMA, INC. : Results of Operations and Financial Condition, Financial Statements..
AQ
08/05ANTARES PHARMA : Q2 Earnings Snapshot
AQ
08/05ANTARES PHARMA : Reports Second Quarter 2021 Financial and Operating Results
AQ
07/28Antares Pharma to Report Second Quarter 2021 Financial and Operating Results
GL
07/22ANTARES PHARMA : Announces FDA Acceptance of IND Application for ATRS 1902 For Adrenal Cri..
PU
07/22Antares Pharma Announces FDA Acceptance of IND Application for ATRS-1902 for Adrenal Cr..
GL
07/07Antares Pharma to Present at the Ladenburg Thalmann Annual Healthcare Conference
GL
06/28Antares Pharma Announces Partner Idorsia Initiates the Phase 3 Study With Selatogrel fo..
GL
06/22Antares Pharma Announces Submission of IND Application for ATRS-1902 for Adrenal Crisis..
GL
06/15ANTARES PHARMA, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/15Antares Pharma to Present at the Raymond James Human Health Innovations Conference
GL
06/01ANTARES PHARMA, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8..
AQ
05/26Antares Pharma to Present at the Jefferies Virtual Healthcare Conference
GL
05/06ANTARES PHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS O..
AQ
05/06ANTARES PHARMA : Q1 Earnings Snapshot
AQ
05/06ANTARES PHARMA, INC. : Results of Operations and Financial Condition, Financial Statements..
AQ
05/06Antares Pharma Appoints Joseph Renda as Senior Vice President of Commercial
GL
05/06ANTARES PHARMA : Reports First Quarter 2021 Financial and Operating Results
AQ
05/03Antares Pharma Announces Poster Presentation at the Pediatric Endocrine Society 2021 Vi..
GL
04/28Antares Pharma to Participate in the 7th Annual Truist Securities 2021 Life Sciences Su..
GL
04/27Antares Pharma to Report First Quarter 2021 Financial and Operating Results
GL
04/26Antares Pharma Appoints Dr. Peter Richardson as Executive Vice President, Research and ..
GL
03/05ANTARES PHARMA, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8..
AQ
03/02ANTARES PHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS O..
AQ
03/02ANTARES PHARMA, INC. : Results of Operations and Financial Condition, Financial Statements..
AQ
03/02ANTARES PHARMA : 4Q Earnings Snapshot
AQ
03/02Antares Pharma Reports Fourth Quarter and Full-Year 2020 Financial and Operating Result..
GL
02/24ANTARES PHARMA : to Present at Two Upcoming Investor Conferences
AQ
02/23ANTARES PHARMA : to Report Fourth Quarter and Full-Year 2020 Financial and Operating Resul..
AQ
02/17Antares Pharma to Participate in the SVB Leerink 10th Annual Virtual Global Healthcare ..
GL
01/11ANTARES PHARMA, INC. : Results of Operations and Financial Condition, Regulation FD Disclo..
AQ
01/11ANTARES PHARMA : Announces Full-Year 2021 Revenue Guidance of $175-200 Million
AQ
2020Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Confe..
AQ
2020Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Confe..
GL
2020ANTARES PHARMA : to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Confer..
AQ
2020ANTARES PHARMA, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8..
AQ
2020ANTARES PHARMA : to Present at the Jefferies Virtual London Healthcare Conference
AQ
2020Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference
GL
2020ANTARES PHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS O..
AQ
2020ANTARES PHARMA : 3Q Earnings Snapshot
AQ
2020ANTARES PHARMA, INC. : Results of Operations and Financial Condition, Financial Statements..
AQ
2020ANTARES PHARMA : Reports Strong Third Quarter 2020 Financial and Operating Results
AQ
2020Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results
GL
2020ANTARES PHARMA : to Report Third Quarter 2020 Financial and Operating Results
AQ
2020ANTARES PHARMA : to Report Third Quarter 2020 Finanical and Operating Results
PU
2020ANTARES PHARMA : to Report Third Quarter 2020 Financial and Operating Results
AQ
2020Antares Pharma to Report Third Quarter 2020 Financial and Operating Results
GL
2020Antares Pharma Enters Exclusive License Agreement with Ferring Pharmaceuticals For Nocd..
AQ
2020ANTARES PHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020ANTARES PHARMA : Enters Exclusive License Agreement With Ferring Pharmaceuticals for Nocdu..
AQ
2020Antares Pharma Enters Exclusive License Agreement With Ferring Pharmaceuticals for Nocd..
GL
2020ANTARES PHARMA, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Fi..
AQ
2020ANTARES PHARMA : to Present at the H.C. Wainwright 22nd Annual Global Virtual Investment C..
AQ
2020Antares Pharma to Present at the H.C. Wainwright 22nd Annual Global Virtual Investment ..
GL
2020Antares Pharma Appoints Tram Bui as Vice President of Corporate Communications and Inve..
GL
2020ANTARES PHARMA : Reports Strong Second Quarter 2020 Operating and Financial Results, Reins..
AQ
2020ANTARES PHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS O..
AQ
2020ANTARES PHARMA : 2Q Earnings Snapshot
AQ
2020ANTARES PHARMA, INC. : Results of Operations and Financial Condition, Financial Statements..
AQ
2020Antares Pharma Reports Strong Second Quarter 2020 Operating and Financial Results; Rein..
GL
2020Antares Pharma and Lunatus Enter Into an Exclusive Distribution Agreement for XYOSTED® ..
GL
2020ANTARES PHARMA : to Report Second Quarter 2020 Operating and Finanical Results
PU
2020Antares Pharma to Report Second Quarter 2020 Operating and Financial Results
GL
2020ANTARES PHARMA : First Commerical Product Using Antares Pharma's Multi-Dose Pen Platform L..
PU
2020First Commercial Product Using Antares Pharma's Multi-Dose Pen Platform Launches in Eu..
GL
2020ANTARES PHARMA : Appoints Patrick Shea Senior Vice President of Commerical
PU
2020Antares Pharma Appoints Patrick Shea Senior Vice President of Commercial
GL
2020ANTARES PHARMA, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
2020Antares Pharma to Present at the Raymond James Human Health Innovation Conference
GL
2020Antares Pharma to Present at the Jefferies Virtual Healthcare Conference
GL
1  2  3  4  5  6Next
Upcoming event on ANTARES PHARMA, INC.